Montserrado County Flag
PREVAIL Team To Extend Study To Distant Counties
MONROVIA, October 19 (LINA) - The Liberia-U.S. Joint Clinical Research Partnership also known as the Partnership for Research on the Ebola Virus in Liberia (PREVAIL) has announced that it will shortly extend its outreach and awareness exercises to distant counties.
It said counties targeted are those hardest hit by the Ebola Virus Disease (EVD) in the country.
According to the Advocacy Lead of PREVAIL, Mr. Joseph Boye Cooper, “very soon the PREVAIL social mobilization, advocacy and community engagement team will visit Bong, Nimba and Lofa counties to increase awareness about the ongoing PREVAIL clinical research for Ebola survivors and their close contacts.
Cooper was speaking Tuesday at the Monrovia City Hall during a one-day national stakeholders advocacy engagement forum with traditional, community, religious and local leaders as well as heads of women, youth, civil society and professional groupings.
Mr. Cooper explained that PREVAIL is reaching out to Ebola survivors and their close contacts in the three counties to attract them to the clinical research.
According to a press statement, he indicated that having intensified the outreach exercises in communities in Montserrado and Margibi Counties since the launch of the Ebola Natural History Study (ENHS) or clinical research over a year ago, the PREVAIL outreach team is going all out to ensure that Ebola survivors in every part of the country are encouraged to join the clinical research so that causes of
their perennial post-Ebola medical complications can be determined and addressed.
Mr. Cooper used the occasion to admonish traditional leaders, including chiefs at the program, to extend this message to their counterparts in the targeted counties during their regular meetings, so that the PREVAIL outreach team will be welcomed by stakeholders in the three counties during visitations.
In her opening remarks earlier, PREVAIL’s Lead on Community Engagement, Ambassador Juli Endee, whose organization, the Liberia Crusaders for Peace (LCP) is executing the community engagement exercise of PREVAIL noted that it was community engagement by community residents in Liberia that brought a halt to the rampaging Ebola Virus Disease in Liberia in 2014.
In her briefings on the research and the Ebola Natural History Study (ENHS), Dr. Jestina Doe-Anderson of PREVAIL explained the genesis of the research beginning with PREVAIL-1 (the vaccine study), PREVAIL-2, the Z-Mapp study drug for Ebola patients, PREVAIL-3, the Ebola Natural History Study and PREVAIL-4, which is meant for male Ebola survivors over the age of 18.
She also explained in brief, the seven sub-studies of the ENHS.
The interactive forum was climaxed by questions and answers to provide better understanding to stakeholders who are expected to take the messages to their communities and people.